BRCA1 and breast carcinoma: This study used a gene panel sequencing approach to screen a consecutive series of unselected New Zealand female breast cancer patients for pathogenic variants in any of six high-risk breast cancer susceptibility genes (BRCA1, BRCA2, CDH1, PALB2, PTEN and TP53) and subsequently assessed the identified carriers for their eligibility for testing using national guidelines.